BioCentury
ARTICLE | Clinical News

Velneperit: Phase IIb data

February 23, 2009 8:00 AM UTC

Top-line data from a double-blind, U.S. Phase IIb trial in 656 modified intent-to-treat (mITT) patients showed that once-daily 800 and 1,600 mg velneperit in combination with a reduced calorie diet me...